Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio‐Receptors
Authors:
- Sharmistha ChatterjeeSCSharmistha Chatterjee
- Rituparna BhaduriRBRituparna Bhaduri
- Arka BagchiABArka Bagchi
- 28 January 2026
- journal article
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 21 (2) , e70593
Abstract
Herein, picolinamide (pica) and sulfur chelated Pt(II) complexes were focused to investigate for their bioactivity and cytotoxic property. For better anticancer activity and less toxicity of Pt(II) complex, l ‐cysteine (L‐cys) and N‐acetyl‐ l ‐cysteine (N‐acetyl‐ l ‐cys) were used to synthesize Pt(II) complexes. Complex [Pt(pica)(OH 2 ) 2 ](NO 3 ) 2 , C‐2 was obtained on hydrolysis of [Pt(pica)Cl 2 ], C‐1 . The complex [Pt(pica)( l ‐cys)] + ; C‐3 and [Pt(pica)(N‐ac‐ l ‐cys)]; C‐4 were synthesized from C‐2 with thiols l ‐cys and N‐ac‐ l ‐cys, respectively. The binding activity of Pt(II) complexes with DNA and BSA were performed for their binding mode and binding constants. The binding modes of the Pt(II) complexes were executed by electronic and fluorescence spectroscopic methods. Synchronous and 3D fluorescence spectroscopic investigations were performed to observe the insight interaction and conformational change of BSA, when interacts with the complex. The drug likeness property was conducted by PASS prediction and ADMET software programs. Molecular docking of the complexes was carried out with DNA, HSA, and HER‐2 cancer protein. The cytotoxic activity of the complexes was tested on breast cancer cell lines; MCF‐7, MDA MB‐231 and normal human embryonic kidney HEK293T cells. Necrotic cell death mechanism was confirmed by Annexin‐V‐FITC/PI assay by flow cytometric method and the production of reactive oxygen species (ROS) was assessed through DCFDA assay.Keywords
This publication has 62 references indexed in Scilit:
- Synthesis and structural characterization of picolinamide and thiol chelated Pt(II) complexes: Their kinetics & mechanism and theoretical approachInorganica Chimica Acta, 2024
- Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconateEuropean Journal of Medicinal Chemistry, 2021
- Studying non-covalent drug–DNA interactionsArchives of Biochemistry and Biophysics, 2015
- Molecular drug design, synthesis and crystal structure determination of CuII–SnIV heterobimetallic core: DNA binding and cleavage studiesEuropean Journal of Medicinal Chemistry, 2012
- Multispectroscopic DNA interaction studies of a water-soluble nickel(II) complex containing different dinitrogen aromatic ligandsTransition Metal Chemistry, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug DesignEuropean Journal of Inorganic Chemistry, 2009
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Fluorescence lifetime analysis of DNA intercalated ethidium bromide and quenching by free dyeBiophysical Chemistry, 1994
- Photoluminescence and chemiluminescence methods of drug analysisJournal of Pharmaceutical and Biomedical Analysis, 1983